Robert R Ruffolo - Net Worth and Insider Trading

Robert R Ruffolo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert R Ruffolo owns 4 companies in total, including Aridis Pharmaceuticals Inc (ARDS) , CervoMed Inc (CRVO) , and Sigilon Therapeutics Inc (SGTX) among others .

Click here to see the complete history of Robert R Ruffolo’s form 4 insider trades.

Insider Ownership Summary of Robert R Ruffolo

Ticker	Comapny	Transaction Date	Type of Owner
ARDS	Aridis Pharmaceuticals Inc	2018-08-13	director
CRVO	CervoMed Inc	2017-06-29	director
SGTX	Sigilon Therapeutics Inc	2020-12-03	director
		2023-06-01	director

Robert R Ruffolo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert R Ruffolo Ownership Network

Ownership Network List of Robert R Ruffolo

No Data

Ownership Network Relation of Robert R Ruffolo

Robert R Ruffolo Owned Company Details

What does Aridis Pharmaceuticals Inc do?

Who are the key executives at Aridis Pharmaceuticals Inc?

Robert R Ruffolo is the director of Aridis Pharmaceuticals Inc. Other key executives at Aridis Pharmaceuticals Inc include 10 percent owner Fibrosis Foundation Cystic , Chief Medical Officer Hasan Jafri , and director & 10 percent owner & CEO & CSO & Director Vu Truong .

Aridis Pharmaceuticals Inc (ARDS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aridis Pharmaceuticals Inc (ARDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aridis Pharmaceuticals Inc (ARDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aridis Pharmaceuticals Inc (ARDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aridis Pharmaceuticals Inc Insider Transactions

No Available Data

What does CervoMed Inc do?

Who are the key executives at CervoMed Inc?

Robert R Ruffolo is the director of CervoMed Inc. Other key executives at CervoMed Inc include director & 10 percent owner Sylvie Gregoire , Chief Financial Officer John William Tanner , and VP & Clinical Development Kelly Blackburn .

CervoMed Inc (CRVO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CervoMed Inc (CRVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CervoMed Inc (CRVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CervoMed Inc (CRVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

CervoMed Inc Insider Transactions

No Available Data

What does Sigilon Therapeutics Inc do?

Who are the key executives at Sigilon Therapeutics Inc?

Robert R Ruffolo is the director of Sigilon Therapeutics Inc. Other key executives at Sigilon Therapeutics Inc include 10 percent owner Lilly Eli & Co , 10 percent owner Shenandoah Acquisition Corp , and CHIEF OF STAFF AND CLO Matthew Paul Kowalsky .

Sigilon Therapeutics Inc (SGTX) Insider Trades Summary

Over the past 18 months, Robert R Ruffolo made no insider transaction in Sigilon Therapeutics Inc (SGTX). Other recent insider transactions involving Sigilon Therapeutics Inc (SGTX) include a net purchase of 1,718,493 shares made by Lilly Eli & Co ,

In summary, during the past 3 months, insiders sold 0 shares of Sigilon Therapeutics Inc (SGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sigilon Therapeutics Inc (SGTX) were sold and 1,718,493 shares were bought by its insiders, resulting in a net purchase of 1,718,493 shares.

Sigilon Therapeutics Inc (SGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sigilon Therapeutics Inc Insider Transactions

No Available Data

What does Elicio Therapeutics Inc do?

Who are the key executives at Elicio Therapeutics Inc?

Robert R Ruffolo is the director of Elicio Therapeutics Inc. Other key executives at Elicio Therapeutics Inc include Chief Financial Officer Brian Piekos , See Remarks Christopher Haqq , and director & CEO & President and Director Robert Connelly .

Elicio Therapeutics Inc (ELTX) Insider Trades Summary

Over the past 18 months, Robert R Ruffolo made no insider transaction in Elicio Therapeutics Inc (ELTX). Other recent insider transactions involving Elicio Therapeutics Inc (ELTX) include a net purchase of 1,213,000 shares made by Yekaterina Chudnovsky ,

In summary, during the past 3 months, insiders sold 0 shares of Elicio Therapeutics Inc (ELTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elicio Therapeutics Inc (ELTX) were sold and 1,213,000 shares were bought by its insiders, resulting in a net purchase of 1,213,000 shares.

Elicio Therapeutics Inc (ELTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elicio Therapeutics Inc Insider Transactions

No Available Data

Robert R Ruffolo Mailing Address

Above is the net worth, insider trading, and ownership report for Robert R Ruffolo. Currently GuruFocus does not have mailing address information for Robert R Ruffolo.

Discussions on Robert R Ruffolo

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.